Ophthalmic use: Prevention of acute allergic conjunctivitis, seasonal conjunctivitis, and vernal keratoconjunctivitis.

Nasal use: Used for the prevention and symptomatic treatment of seasonal or perennial allergic rhinitis. For prophylaxis in seasonal allergic rhinitis, treatment should be started 2–3 weeks before allergen exposure and continued throughout the allergy season.

Sodium Cromoglicate is an antiallergic medicine used to prevent allergic symptoms. It acts by stabilizing mast cells and preventing the release of chemical mediators responsible for allergic reactions.

Sodium Cromoglicate works by inhibiting the degranulation of sensitized mast cells following exposure to specific antigens. It blocks the release of histamine and other inflammatory mediators from mast cell membranes. It has no antihistaminic or vasoconstrictor activity.

For eyes: For Child and Adult: 1 to 2 drops into each eye 2 to 3 times daily.

For nose: For Child and Adult: 1 drop to each nostril 2 to 3 times daily

No evidence of clinically significant interaction with other drugs has been observed.

This eye drop is contraindicated in patients with known hypersensitivity to Sodium Cromoglicate.

Temporary stinging or burning sensation may occur after instillation. Rarely, other local irritation symptoms have been reported.

Sodium Cromoglicate should be used during pregnancy only if the expected benefit outweighs the potential risk to the fetus. No harmful effects have been reported in breastfeeding mothers.

This eye drop contains benzalkonium chloride; therefore, contact lenses should not be worn during treatment.

Overdose is unlikely. If accidentally swallowed, symptomatic treatment should be given.

Mast cell stabiliser, ophthalmic non-steroidal drugs

Store at room temperature, protected from light. Discard any remaining solution 4 weeks after opening. Do not touch dropper tip to any surface to avoid contamination.